1.1 Scope of Research

1.2 Research Process Methodology

1.2 Research Methodology Explained

1.3 Key Findings

2.1 Adoption of Cochlear Implants Remains Extremely High in Developed Nations

2.2 Cochlear Implants Market Remains Consolidated Even after Decades

2.3 IP Scenario of Cochlear Implant Manufacturers

3.1 Sizeable Addressable Market for Retinal Implants

3.2 Flexible Regulations to Boost the Commercialization of Retinal Implants

3.3 IP Scenario of Top Patent Assignees in Retinal Implants

4.1 Spinal Cord Stimulation Continues to Attract Maximum Adoption

4.2 Leadless Neurostimulators with Prolonged Battery Life Expected in the Future

4.3 Medtronic Offers the Largest Range of Implantable Neurostimulators

4.4 Hypoglossal Nerve Stimulation among the Most Researched Modulation Techniques in Recent Times

4.5 IP Scenario of Companies Developing Implantable Neurostimulators

5.1 Implantable Infusion Pumps Hold Promise in Delivering Sustained-Release Medications

5.2 Better Insurance Coverage Expected for Implantable Infusion Pumps

5.3 IP Scenario of Top Patent Assignees in Implantable Infusion Pumps

6.1 Prospects for Implantable Sensors in Continuous Glucose Monitoring (CGM)

6.2 Eversense Remains the Only Commercially Available Implantable CGM

6.3 IP Scenario of Companies Developing Implantable CGMs

7.1 Cardiovascular Implantable Devices Segment is the Most Mature in the Implantable Electronics Sector

7.2 Cardiac Pacemakers will Continue to Enjoy Maximum Share in the Cardiovascular Segment

7.3 Better Compatibility with MRI has Boosted the Growth of CIEDs

7.4 IP Scenario of Top Patent Assignees Developing Cardiovascular Implantable Devices

8.1 Regulatory Bodies and Insurance Coverage Hold Maximum Weightage in the Value Chain

8.2 Market Drivers

8.3 Drivers Explained

8.3 Drivers Explained (continued)

8.4 Market Challenges

8.5 Challenges Explained

8.5 Challenges Explained (continued)

9.1 Payers and Providers Hold Significance in Insurance Coverage

9.2 North America is the Strongest Region for Implantable Device Insurance Coverage

9.3 Europe Presents a Mature Private Health Insurance Model

9.4 Increasing Focus on Healthcare Reforms in the Asia-Pacific Region

10.1 Cardiovascular and Cochlear Implants Research Receives Maximum Funding from the NIH

10.2 NIH Funds Some of the Key Groundbreaking Projects in Implantable Electronics

10.3 Supportive Government Funding for Development of Retinal Implants

10.4 Private Investors Demonstrate Encouraging Sponsorship toward Neurostimulator Manufacturers

10.5 Development of Implantable Infusion Pumps Requires Substantial Support from Collaborators and Investors

10.6 Cochlear Implant Manufacturers Experience Positive Growth Due to Solid YoY Revenues

10.7 Huge Investments from Private Investors Boost the R&D Efforts for Implantable CGMs

10.8 Cardiovascular Implants Remain Active Space for M&As

11.1 Next-Generation Cochlear Implants to Showcase Rapid Wireless Charging

11.2 Neuroprosthetics to be Integrated with Wearable Neurostimulation

11.3 Internet-of-Things (IoT) is Expected to be Integrated with a Number of Implantable Devices in the Future

11.4 Strategic Recommendations for Global Manufacturers

12.1 Growth Opportunity 1: Point-of-Care Neurostimulation

12.2 Growth Opportunity 2: Smart Bandages for Wound Care

12.3 Growth Opportunity 3: Electroceuticals

12.4 Growth Opportunity 4: Continuous Glucose Monitoring

12.5 Growth Opportunity 5: Smarter Drug Delivery

12.6 Strategic Imperatives for Success and Growth of Implantable Electronics

13.1 Global Patents

13.1 Global Patents (continued)

13.1 Global Patents (continued)

13.1 Global Patents (continued)

13.1 Global Patents (continued)

13.2 Key Contacts

13.3 Legal Disclaimer

14.1 The Frost & Sullivan Story

14.2 Value Proposition: Future of Your Company & Career

14.3 Global Perspective

14.4 Industry Convergence

14.5 360º Research Perspective

14.6 Implementation Excellence

14.7 Our Blue Ocean Strategy